Discontinuation of Protelos (strontium ranelate) 2g granules for oral suspension

· London and South East Regional Medicines Information Service

Servier will cease production and distribution of strontium ranelate at the end of August 2017. This worldwide and strategic decision has been taken for commercial reasons. This memo discusses alternative treatment options and signposts relevant NICE guidance.

Musculo-skeletal disordersNewsShortages and discontinuationsStrontium ranelate

Attachments